Xeris Pharmaceuticals | XERS - 应收帐款人

金融业

USD

USD 392.01M

现金及等价物

USD 111.75M

USD 13.66M

USD 251.68M

USD 118.59M

USD 257.65M

USD 16.77M

USD 25.09M

377

EPS每股收益

USD 0.01

股本和储备

USD 13.01M

USD 72.15M

债务利息支出

USD 7.15M

USD 1.16M

USD 221.22M

USD 844.1M

USD 11.08M

USD 69.03M

USD 16.77M

普通股股本

USD 166.22M

2.45K

USD 11.08M

USD 83.13M

销售和管理费用

USD 42.64M

USD 74.23M

贸易债权人

USD 11.47M

应收帐款人

USD 51.05M

	应收帐款人	更改		日
Celltrion	KRW 2.05T		542.39B	2025-12
Cspc Pharmaceutical	CNY 8.79B		64.64M	2025-12
Deva Holding AS	TRY 3.03B		343.23M	2023-09
Dianthus Therapeutics	USD 52K		4.95M	2025-12
Divis Laboratories Ltd	INR 26.28B		1.16B	2025-09
Eli Lilly	USD 21.18B		1.02B	2026-03
Kangmei Pharma	CNY 3.15B		295.48M	2025-09
Knight Therapeutics	CAD 183M		7.46M	2025-12
Laboratorios Farma	EUR 143.38M		16.93M	2023-12
Malin Corporation	EUR 500K		300K	2024-12
Medical Developments International	AUD 7.48M		174K	2025-12
Nektar Therapeutics	USD 1.78M		1.12M	2025-12
Neuren Pharmaceuticals	AUD 26.54M		5.83M	2025-12
Organigram Holdings	CAD 49.94M		14.92M	2025-12
Ovoca Bio	EUR 39K		408K	2025-06
Pacira	USD 125.64M		1.57M	2026-03
Perrigo	USD 697.1M		84.3M	2026-03
Pharma Mar	EUR 51.19M		9.4M	2026-03
Qiagen NV	USD 402.61M		9.05M	2025-12
Sartorius	EUR 366.6M		74.9M	2026-03
Sino Biopharmaceutical	CNY 8.45B		3.18B	2025-06
Supernus Pharmaceuticals	USD 182.18M		5.62M	2026-03
Tilray	USD 109.07M		2M	2025-09
Zealand Pharma A/S	340M		94.1M	2025-12
Zz Pientze Pharmaceu	CNY 1.06B		60.42M	2026-03